NCT02231853 2019-12-17Phase I/II Trial of Early Infusion of Rapidly-generated Multivirus Specific T Cells (MVST) to Prevent Post Transplant Viral InfectionsNational Institutes of Health Clinical Center (CC)Phase 1 Terminated12 enrolled